AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
CytomX Therapeutics announced that CEO Sean McCarthy will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 20, 2025. A live webcast of the presentation will be available on the company's website. Management will also be available for one-on-one meetings with investors. CytomX is a clinical-stage biopharmaceutical company focused on developing conditionally activated, masked biologics for oncology.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet